In Greek mythology Hesiod tells of Pandora, the first woman created by Zeus, to whom he presented a box containing all the spirits of misery and evil with the admonition never to open it. With typical feminine curiosity, Pandora opened the lid -and out flew plagues innumerable, sorrows, miseries and mischief. In terror she clamped down the lid, but too late: the evil spirits were free to roam the earth forever, bringing misfortune to the human race. But all was not wicked in the contents of Pandora's Box: some virtues, particularly Hope, remained harnessed to provide some good to mankind.
In modern nephrology, we find a parallel-the story of acetate as a buffering agent in dialysate. Introduced by Mion et al. in 1964 (1) as an easy was of providing bicarbonate together with calcium in large-scale dialysis, it was immediately accepted into widespread use. At that time there was little concern about the possible untoward effects of acetate on acid-base balance, lipids, heart, and peripheral vessels. Yet as early as 1962 Lundquist (2) had estimated that the maximal rate at which free acetate could be metabolized in adults was about 5 mEq/min. Later Gonzalez et al. (3) demonstrated that the acetate infusions during hemodialysis approached this level and predicted that an acetate intolerance syndrome might develop in some dialysis patients.
It was not surprising then, when our group (5) first observed instances of marked elevation in serum acetate concentration during dialysis (as high as 15 mEq/liter) associated with a substantial reduction in serum bicarbonate level in three patients. These data, obtained with high efficiency dialyzers, indicated that the acetate accumulated because of a relatively low metabolic rate; and similar observations were later made by Port et al. (6) , who reported post dialysis acetate concentrations of 10 to 21.8 mEq/liter in 17% of their patients. Thus, an acetate related syndrome came to be recognized, characterized by nausea, vomiting, headaches, post dialysis fatigue, and hypotension (7) . Sub-sequent reports also incriminated acetate as an undesirable choice for fixed base in the hemodialysis bath (8) (9) (10) . Furthermore, as high-efficiency, large-surface area dialyzers were developed, the augmented acetate loads further increased the likelihood of adverse effects from the buffer. Meanwhile the report by Graefe and others (7) suggested that replacing the acetate in the dialysate with bicarbonate decreased dialysate induced morbidity. Specifically it reduced the incidence of hypotension despite fluid removal by ultrafiltration, suggesting that vascular instability was not primarily due to rapid volume changes characteristic of large dialyzers or to excessive ultrafiltration. Bergstrom et al. (8) also observed that dialysis with bicarbonate seemed to cause less hypotension than with acetate; and earlier still, Frohlich (4) had reported that acetate and other intermediary metabolites of the Krebs cycle had a depressant effect on the cardiovascular system.
The cardiac and vascular effects of infused acetate and bicarbonate in intact dogs were studied by Kirkendol's group (9) , who found that bicarbonate produced little change except for a slight increase in cardiac output. By contrast, acetate produced a variety of cardiovascu lar effects, including generalized vasodilatation, an increased heart rate, and a marked decrease in myocardial contractility. Blood pressure fell only slightly, probably because of reflex sympathetic stimulation. In the dialysis patient with limited cardiac reserve, the administration of acetate (with its myocardial depressing action and peripheral vasodilatation) may well reduce cardiac output and cause profound hypotension; but this effect is clinically observed only in a small percentage of dialysis patients.
It has also been considered that acetate may be responsible for the hyperlipidemia frequently seen in chronic hemodialysis patients (11) . This was attributed to the rapid conversion of acetate to acetyl coenzyme A, with subsequent formation of triglycerides and cholesterol. Indeed, a small but possibly important portion of infused acetate may well be available to enter alternate metabolic pathways such as lipogenesis (10, 12, 13 ); yet Savdie et al. (14) could not demonstrate a consistent or significant change in cholesterol ortriglyceride levels, following prolonged use of acetate containing dialysate, suggesting that acetate does not play an important role in the genesis of the hyperlipidemia.
It is worth noting, then, that despite some adverse reports from the use of acetate the incidence of documented noxious effects has been largely limited to special clinical circumstances: acutely ill patients with severe uremia or uncompensated metabolic acidosis, children, the elderly (particularly those with severe cardiovascular disease, hypo-perfusion and a tendency towards tissue hypoxia) patients with limited cardiac reserve and unstable sympathetically innervated vasculatu re and, in general, those unable to rapidly shunt acetate into the tricarboxylic acid cycle.
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One may conclude, then, that acetate appears to remain the buffer of choice in the stable uncomplicated maintenance dialysis patient. On the other hand, patients with limited cardiac reserve, with precarious acute or complicated clinical conditions, or with a tendency to develop severe acid-base imbalances, would clearly benefit from the use of bicarbonate. These patients however are by far in the minority. Stable chronic dialysis patients have little tendency to develop acute acid-base imbalances, they generally adjust well to the hemodynamic challenges presented by acetate and ultrafiltration, and the rapidly generate bicarbonate in response to acetate infusion.
Thus, returning to our Greek parable, the evil spirits of acetate-related problems continue to roam the earth, yet on balance, under the auspicious influence of Hope, their harmful effects are not as numerous as initially suggested, being confined to a minority of high-risk individuals. It would seem that the routine use of acetate in the stable dialysis patients is safe, and that bicarbonate should be substituted only when the clinical setting calls for it. First described in 1970 (1, 2) , refractory ascites remains a poorly understood complication of long-term hemodialysis. To a certain extent it is a diagnosis of exclusion, because other causes of peritoneal fluid accumulation, such as hepatic cirrhosis, congestive heart failure, pericardial constriction or tamponade, myxedema, pancreatitis, inferior vena caval obstruction, tuberculous peritonitis, and abdominal malignancy must be ruled out. Yet a certain number of patients will remain whose ascites appears to be related merely to end-stage renal disease and dialysis.
The presentation of dialysis ascites is variable, there being no truly characteristic clinical or laboratory findings (3) . Some patients develop swelling of the abdomen only, whereas others manifest signs of fluid excess elsewhere in the body; e.g., in the form of pleural effusion or peripheral edema. Cardiac or hepatic dysfunction is not usually found, but the serum protein level may be low. The ascitic fluid itself is typically high in protein content, suggesting an exudative process. The peritoneal fluid cell count, however, is normal. Microscopy of the peritoneal membrane is usually unremarkable (3), al-though it may reveal mild, chronic, inflammatory changes (4) or slight mesothelial cell proliferation (5) .
Early investigators suggested that «dialysis ascites» was associated with a grave prognosis (1, 2) . It has been speculated that abdominal distension and commonly associated psychologic depression limit food intake and that the resulting cachexia hastens these patients' ultimate demise (5) . Later reports, however, have described a response to various forms of treatment, so that a fatal outcome is not necessarily the rule (3, 4, (6) (7) (8) (9) .
The pathogenesis of «dialysis ascites» has been a subject of much debate. Early reports incriminated prior peritoneal dialysis. Subsequently, ascites was noted in patients who had never received such therapy. Overhydration appears to be a common initiating factor, and fluid overload, coupled with a propensity of uremic patients to develop serosal inflammation, may lead to fluid accumulation in the peritoneal cavity (3, 10) . Increased vascular permeability may also playa role. Finally, «dialysis ascites» may represent a number of different disease processes, each with its own, as yet unrecognized, etiologic mechanism.
So far, the mainstay of treatment has been sodium and water restriction, together with removal of excess fluid by dialytic ultrafiltration (ultrafiltration during dialysis) (3). Eknoyan et al. (10) demonstrated that the peritoneal fluid volume could be reduced by dialytic ultrafiltration, provided enough ultrafiltrate was removed from the circulation. However, it is easier to mobilize peripheral edema than ascitic fluid in these patients (3) . Furthermore, patients with dialysis ascites are notoriously prone to develop hypotension during dialytic ultrafiltration, perhaps because of the unfavourable changes in cardiovascular function induced by the tightly distended abdomen (4) . When hypotension does occur, ultrafiltration must be discontinued, and substantial volumes of intravenous fluid may be required to maintain blood pressure. As a result, removal of excess fluid is inadequate, and control of ascites is not achieved. Perhaps for this reason, isolated ultrafiltration (ultrafiltration without dialysis) (11) -which is tolerated better than dialytic ultrafiltration in general as a method of fluid removal from overhydrated patients -has been more successful in the treatment of dialysis ascites (9) . Another proposed advantage of isolated ultrafiltration concerns the osmotic balance between the ascitic fluid and plasma compartments. During hemodialysis, the urea level falls more rapidly in the blood than in the ascitic fluid. The resulting osmotic pressure gradient may promote an unwanted shift of fluid from the blood to the peritoneal cavity. Such a shift would not be expected to occur with isolated ultrafiltration, during which plasma osmolality remains constant (9) .
Paracentesis may acutely relieve abdominal swelling,
